Search

everythinglearnresearchcommunity

for

Search:↓

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

Dupilumab for skin problems might reactivate hair loss in some patients.

Canine pemphigus foliaceus involves significant immune activity and shares similarities with human pemphigus.

Psoriasis may be chronic because it lacks certain immune system controls that prevent overreaction.

Papulopustular rosacea is an inflammatory skin condition treatable with lifestyle changes and medications.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

An imbalance in gut bacteria is linked to skin immune diseases and may affect their outcomes and related health issues.

Low vitamin D levels are linked to different types of hair loss.

TNC+ fibroblasts play a key role in skin inflammation by interacting with T cells.

Accurate diagnosis of pseudolymphomatous folliculitis is crucial to avoid mistaking it for more serious conditions.

UV light helped human hair transplants survive in mice without broad immunosuppression.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

Melatonin could be an effective treatment for Alzheimer's Disease and rosacea.

A protein called lfTSLP is important in causing allergic and other skin diseases and could be a target for treatment.

People with Alopecia Areata are more likely to have autoimmune diseases, inflammatory diseases, and mental health issues like anxiety and depression.

Rabbits with Sarcoptes scabiei had thicker skin, cell death, and skin hardening.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

New treatments for hair loss are showing promise due to better understanding of genetics and the immune system.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Atopic dermatitis in kids with alopecia areata can predict poor response to topical immunotherapy.

Wigs help improve self-esteem and quality of life for people with hair loss from alopecia areata.

Different parts of the body have unique immune characteristics in their skin.

Targeted cytokine treatments may help with alopecia areata, but more research is needed.

Alopecia areata is a hair loss disease caused by complex immune reactions, and new targeted treatments show promise.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Lower CD200R1 on certain immune cells is linked to more severe rheumatoid arthritis and immune imbalance.

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.